Insulin glargine and lixisenatide and Sarecycline Hydrochloride
Determining the interaction of Insulin glargine and lixisenatide and Sarecycline Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: sarecycline
Brand name: Seysara
Synonyms: Sarecycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Sargramostim
- Insulin glargine and lixisenatide-Sargramostim Intravenous
- Insulin glargine and lixisenatide-Sargramostim Powder for Injection
- Insulin glargine and lixisenatide-Sargramostim Solution for Injection
- Insulin glargine and lixisenatide-Sarilumab
- Insulin glargine and lixisenatide-Sarilumab Prefilled Pens
- Sarecycline Hydrochloride-Insulin glargine and lixisenatide Subcutaneous
- Sarecycline Hydrochloride-Insulin glargine, recombinant Subcutaneous
- Sarecycline Hydrochloride-Insulin glulisine
- Sarecycline Hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Sarecycline Hydrochloride-Insulin Glulisine (Vials)
- Sarecycline Hydrochloride-Insulin glulisine Subcutaneous